Rubra Medicaments reports standalone net loss of Rs 0.01 crore in the March 2020 quarter

Sales rise 110.00% to Rs 0.63 crore

Net loss of Rubra Medicaments reported to Rs 0.01 crore in the quarter ended March 2020 as against net profit of Rs 0.13 crore during the previous quarter ended March 2019. Sales rose 110.00% to Rs 0.63 crore in the quarter ended March 2020 as against Rs 0.30 crore during the previous quarter ended March 2019.

For the full year,net profit reported to Rs 0.03 crore in the year ended March 2020 as against net loss of Rs 0.01 crore during the previous year ended March 2019. Sales rose 67.80% to Rs 0.99 crore in the year ended March 2020 as against Rs 0.59 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales0.630.30 110 0.990.59 68 OPM %-4.76-13.33 -1.01-30.51 - PBDT-0.03-0.04 25 0.01-0.18 LP PBT-0.03-0.04 25 0.01-0.18 LP NP-0.010.13 PL 0.03-0.01 LP

Powered by Capital Market - Live News